Diagnostics & Research
The Diagnostics & Research industry has a total of 52 stocks, with a combined market cap of $648.24 billion, total revenue of $163.74 billion and a weighted average PE ratio of 42.72.
Market Cap
648.24B
Revenue
163.74B
Profits
15.17B
PE Ratio
42.72
Profit Margin
9.27%
Dividend Yield
0.22%
52 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 175.30B | 1.09% | 1,890,749 | 43.21B |
| 2 | DHR | Danaher Corporation | 132.35B | 2.22% | 4,855,234 | 24.01B |
| 3 | IDXX | IDEXX Laboratories, Inc. | 50.58B | 2.27% | 345,208 | 4.04B |
| 4 | A | Agilent Technologies, Inc. | 34.98B | 1.23% | 1,170,143 | 6.79B |
| 5 | IQV | IQVIA Holdings Inc. | 30.53B | 1.62% | 928,801 | 15.70B |
| 6 | MTD | Mettler-Toledo International Inc. | 24.81B | -0.42% | 130,329 | 3.87B |
| 7 | LH | Labcorp Holdings Inc. | 23.32B | 1.62% | 404,782 | 13.48B |
| 8 | NTRA | Natera, Inc. | 22.37B | -0.42% | 1,221,762 | 1.96B |
| 9 | DGX | Quest Diagnostics Incorporated | 21.13B | 1.94% | 551,836 | 10.52B |
| 10 | WAT | Waters Corporation | 17.36B | 1.36% | 397,480 | 3.05B |
| 11 | ILMN | Illumina, Inc. | 14.10B | -0.54% | 2,164,940 | 4.28B |
| 12 | MEDP | Medpace Holdings, Inc. | 13.96B | 1.81% | 169,987 | 2.23B |
| 13 | ICLR | ICON Public Limited Company | 12.74B | 0.78% | 593,278 | 8.09B |
| 14 | EXAS | Exact Sciences Corporation | 10.14B | -0.20% | 2,254,904 | 2.94B |
| 15 | RVTY | Revvity, Inc. | 9.76B | 1.23% | 916,713 | 2.80B |
| 16 | QGEN | Qiagen N.V. | 9.52B | -0.07% | 859,814 | 2.04B |
| 17 | GH | Guardant Health, Inc. | 7.49B | -0.25% | 2,344,626 | 828.85M |
| 18 | CRL | Charles River Laboratories International, Inc. | 7.31B | 2.05% | 762,931 | 4.03B |
| 19 | RDNT | RadNet, Inc. | 5.84B | 1.05% | 349,847 | 1.91B |
| 20 | SHC | Sotera Health Company | 4.49B | 1.80% | 1,166,474 | 1.12B |
| 21 | WGS | GeneDx Holdings Corp. | 3.37B | 3.76% | 433,851 | 362.32M |
| 22 | HTFL | HeartFlow, Inc. | 2.77B | -2.54% | 384,019 | 148.54M |
| 23 | VCYT | Veracyte, Inc. | 2.63B | 1.89% | 831,143 | 479.13M |
| 24 | GRAL | GRAIL, Inc. | 1.80B | 3.32% | 806,951 | 134.29M |
| 25 | TWST | Twist Bioscience Corporation | 1.62B | 0.60% | 1,257,825 | 362.27M |
| 26 | NEOG | Neogen Corporation | 1.23B | 5.78% | 4,293,632 | 894.66M |
| 27 | OPK | OPKO Health, Inc. | 1.15B | 1.40% | 2,189,041 | 664.03M |
| 28 | NEO | NeoGenomics, Inc. | 1.02B | 0.76% | 1,312,164 | 689.19M |
| 29 | CDNA | CareDx, Inc | 794.68M | 0.47% | 1,581,893 | 340.83M |
| 30 | MYGN | Myriad Genetics, Inc. | 716.44M | -0.77% | 1,269,716 | 832.90M |
| 31 | FLGT | Fulgent Genetics, Inc. | 691.46M | 2.54% | 265,631 | 303.22M |
| 32 | CSTL | Castle Biosciences, Inc. | 658.78M | -0.13% | 160,196 | 346.27M |
| 33 | PSNL | Personalis, Inc. | 535.61M | 1.00% | 895,122 | 80.32M |
| 34 | XGN | Exagen Inc. | 239.62M | 3.03% | 257,889 | 58.86M |
| 35 | MDXH | MDxHealth SA | 229.17M | 7.67% | 240,930 | 98.95M |
| 36 | PRE | Prenetics Global Limited | 163.84M | 2.11% | 74,391 | 57.05M |
| 37 | FONR | FONAR Corporation | 100.63M | 0.92% | 10,355 | 104.35M |
| 38 | BNR | Burning Rock Biotech Limited | 96.15M | 4.28% | 5,572 | 74.86M |
| 39 | IMDX | Insight Molecular Diagnostics Inc. | 95.30M | 2.15% | 23,020 | 4.26M |
| 40 | BDSX | Biodesix, Inc. | 60.45M | -3.25% | 54,015 | 76.56M |
| 41 | NOTV | Inotiv, Inc. | 47.41M | 1.47% | 217,359 | 505.30M |
| 42 | STRR | Star Equity Holdings, Inc. | 39.90M | -0.87% | 16,010 | 137.86M |
| 43 | PRPO | Precipio, Inc. | 28.21M | -3.81% | 24,987 | 21.24M |
| 44 | PRPH | ProPhase Labs, Inc. | 18.39M | 3.43% | 828,824 | 5.59M |
| 45 | CHEK | Check-Cap Ltd. | 12.93M | -2.21% | 317,268 | - |
| 46 | ADVB | Advanced Biomed Inc. | 9.65M | -5.15% | 132,321 | - |
| 47 | ISPC | iSpecimen Inc. | 6.48M | -12.03% | 1,452,118 | 5.91M |
| 48 | XWEL | XWELL, Inc. | 5.99M | 2.97% | 15,670 | 30.60M |
| 49 | APDN | Applied DNA Sciences, Inc. | 5.35M | 42.27% | 7,984,113 | 3.74M |
| 50 | MYNZ | Mainz Biomed N.V. | 5.33M | - | 50,577 | 659.94K |
| 51 | BIAF | bioAffinity Technologies, Inc. | 5.16M | 55.13% | 99,911,199 | 7.68M |
| 52 | NDRA | ENDRA Life Sciences Inc. | 3.94M | 6.95% | 42,130 | - |